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Abstract
Background: Country-of-origin of a product can negatively influence its rating, particularly if the product is from a
low-income country. It follows that how non-traditional sources of innovation, such as low-income countries, are
perceived is likely to be an important part of a diffusion process, particularly given the strong social and cognitive
boundaries associated with the healthcare professions.
Methods: Between September and December 2014, we conducted eleven in-depth face-to-face or telephone
interviews with key informants from innovation, health and social policy circles, experts in international comparative
policy research and leaders in Reverse Innovation in the United States. Interviews were open-ended with guiding
probes into the barriers and enablers to Reverse Innovation in the US context, specifically also to understand
whether, in their experience translating or attempting to translate innovations from low-income contexts into the
US, the source of the innovation matters in the adopter context. Interviews were recorded, transcribed and
analyzed thematically using the process of constant comparison.
Results: Our findings show that innovations from low-income countries tend to be discounted early on because of
prior assumptions about the potential for these contexts to offer solutions to healthcare problems in the US.
Judgments are made about the similarity of low-income contexts with the US, even though this is based
oftentimes on flimsy perceptions only. Mixing levels of analysis, local and national, leads to country-level
stereotyping and missed opportunities to learn from low-income countries.
Conclusions: Our research highlights that prior expectations, invoked by the Low-income country cue, are
interfering with a transparent and objective learning process. There may be merit in adopting some techniques
from the cognitive psychology and marketing literatures to understand better the relative importance of source in
healthcare research and innovation diffusion. Counter-stereotyping techniques and decision-making tools may be
useful to help decision-makers evaluate the generalizability of research findings objectively and transparently. We
suggest that those interested in Reverse Innovation should reflect carefully on the value of disclosing the source of
the innovation that is being proposed, if doing so is likely to invoke negative stereotypes.
Keywords: Peer review, Bias, Diffusion of innovation, Evidence based medicine
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Background
Diffusion of innovation in healthcare is not linear; its
pathway is chaotic and thorny [1]. In the most compre-
hensive review of innovation diffusion in services organi-
zations to date, Greenhalgh et al. [2] compile what is
referred to as the “standard” attributes of an innovation
ripe for adoption. The ideal innovation has relative ad-
vantage, is compatible with the norms of the adopter
context, is perceived as uncomplicated with observable
benefits and finally, holds potential for reinvention. They
also note that the adopter context needs to be ready to
change and be receptive to the innovation. Innovations
should diffuse more readily if the adopter is large, mature,
specialized, and has the resources (human, financial,
organizational etc.) for change [2]. Adopters must be
willing and ready to accept a new idea.
The diffusion of innovation literature is curiously silent
on whether one’s view of the source of an innovation mat-
ters in the diffusion process. Greenhalgh et al. [2] mention
that the innovator-context should be a ‘legitimate’ source
but then does not explain what constitutes ‘legitimate’.
The marketing literature has been far more active in
examining buyers’ perceptions of product country of
origin. Buyers’ perceptions of particular extrinsic informa-
tional cues are one of the most widely studied phenomena
in the international business, marketing, and consumer
behavior literatures [3]. In the marketing industry, there
has been extensive exploration of the relationship between
consumers’ perception of product country of origin and
consumer demand [4]. Much of this literature has focused
on the likelihood that a source country will evoke ei-
ther positive or negative consumer connotations [5–8].
Marketing research shows that when consumers see
“Made in [Country],” this affects their evaluation of the
product [4]. This Country of Origin (COO) effect has
significant influences on perceptions of perceived qual-
ity or risk [3, 4]. There is a tendency for consumers to
evaluate their own country’s products more favorably, as
well as a positive relationship between product evaluations
and degree of economic development of the product’s
country origin [4]. Bilkey and Nes [4] note that a lower
GDP cue is related to lower perceptions of quality and
value. Products developed abroad in general are perceived
as “riskier” than products developed in one’s own country.
US-made products are perceived to be of higher quality
than products made in low-income countries (LICs) and
that specific brands might be evaluated higher or lower
when LIC country of origin was revealed. Overall, country
of origin has significant effects on consumer brand atti-
tudes [9] and the country of origin of a product serves as
a conflated, stereotyped measure for other product
attributes [3]. This parallels behavioral research on
stereotypes, which suggests that individuals use category
membership as a heuristic basis for judgments without
considering more detailed information about the object’s
characteristics [10]. Psychologists call stereotypes ‘cogni-
tive structures schema’, and believe that this schema
simplifies a complex evaluation of something or someone
by quickly processing incoming stimuli based on the pres-
ence of a few relevant characteristics [11]. This may be
compounded by social and cognitive boundaries between
different professions can lead to the “non-spread” of inno-
vations. Communities of practice develop ‘ways of working’
(clinical, intellectual, professional) that can be relatively
inaccessible to non-members of the group. McGivern and
Dopson, refer to this as ‘epistemic communities’ and is a
barrier to the transfer of knowledge, expertise and experi-
ence between groups [12].
The Reverse Innovation ‘movement’ explores the bar-
riers to adopting low-income country (LIC) innovations
in high-income country (HIC) contexts. It is motivated
in part by the rapidly changing global health landscape
and has gained traction in the US and UK because the
unsustainable growth in healthcare expenditure means
that there is likely to be a genuine need to learn from
LICs [13]. LICs have developed novel innovations and
there are multiple opportunities to learn from LICs, for
example around improved surgical procedures [14],
approaches to improve long-term outcomes in mental
illness [15–19] and improved skill mix with scaled use of
community health workers [20–22]. However, there are
strikingly few examples where LIC innovations have been
explicitly adopted in HICs [23]. Drawing on Roger’s diffu-
sion of innovation theory, DePasse advances a diffusion
pathway specifically for Reverse Innovation and emphasize
that Reverse Innovation is a particular type of innovation
diffusion because the learning is non-traditional, going
from a low- to high-income country [24]. They suggest
that a type of “crossover” is required, where ideas begin to
transition from the LIC to the HIC, but shed little light on
how this crossover is carried out other than to say that
network structures within the adopter context must be re-
ceptive to the innovation [24]. In the context of Reverse
Innovation, exploration into individual perceptions of
sources that may be considered to be non-traditional
would seem to be important, particularly given the strong
social and cognitive boundaries associated with the health-
care professions, and yet there is little research that
explores actors’ views of the innovation’s country of origin
and whether it interferes positively or negatively with the
adoption process.
We undertook an exploration of the barriers and
challenges to Reverse Innovation in the US between
September 2014-June 2015. Here we describe our inter-
views with nearly a dozen US experts in healthcare
innovation, international health policy and health sys-
tems, including also experts from other spheres such as
education and social policy, to examine whether, in their
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experience translating or attempting to translate innova-
tions from low-income contexts into the US, the source of
an innovation matters to actors in the adopter context.
Methods
Sampling
Informants were selected purposefully from institutions
and organizations known to have an interest in the
Reverse Innovation space, and attention was given to
ensure that there was representation from academic,
non-profit foundation, health system management and
innovation think tanks. To ensure an even wider repre-
sentation, informants were also identified from both execu-
tive and managerial cadres and from those with experience
or interest in international policy exchange in diverse
disciplinary areas such as healthcare, as well as educational
policy and social policy reform. Eleven participants were
initially identified and all agreed to participate in the inter-
views which were conducted in-person or by telephone.
Data collection
As exploratory research, with a focus on views and expe-
riences, we used an open-ended interview style, loosely
guided by some specific areas of interest, allowing for
free-flowing conversation and examination of divergent
themes [25]. These were to explore experiences of
‘Reverse Innovation’ in the US context, to identify the
barriers and challenges from the informant’s point of
view, and to enquire specifically also into whether per-
ceptions of the innovator context are important in the
adopter context. Informants were first contacted by
email and once the research was explained and agree-
ment to participate obtained, interviews were arranged
for dates, times and locations of their convenience. All
the interviews were audio-recorded and verbatim tran-
scripts were obtained from a commercial transcription
company under strict confidentiality. Written informed
consent was obtained from all informants. Participants
had the right to withdraw their consent at any stage
without giving a reason although none exercised this
right. Potential participants received no inducement to
participate. No identifying information was included in
the transcripts and the informant list is kept securely apart
from any data in a locked filing cabinet. Transcripts were
checked and we removed any identifiable information or
references immediately upon receipt by the research team
and stored them in password-protected files.
All interviews lasted between thirty minutes to an
hour. The research protocol was reviewed by the Univer-
sity Committee on Activities Involving Human Subject
and deemed exempt from full ethical review (IRB# 14–
10294). Interviews were all conducted by the same
researcher (MH), during the period Sept-Nov 2014, and
stopped once thematic saturation was reached.
Analytical strategy
Two researchers (MH and EW) reviewed all the tran-
scripts and using the first four transcripts independently
indexed thematic categories using the process of con-
stant comparison indexing both vertically, within the
same transcript, and horizontally, across the transcripts
[26–29]. These early code structures were then reviewed
and revised for four further iterations, enabling the
codes to be redefined, merged and retired until a final
code structure had been obtained which was used to
then code the remaining transcripts. Both researchers
reviewed all coded transcripts, all of which had been
coded independently using the final agreed code structure
and any coding disagreements were resolved through con-
sensus. The interviews generated over two hundred pages
of verbatim transcript, which was manually coded. Coded
data was organized into themes and sub-themes and the
researchers identified patterns within the categorized data
at higher levels of abstraction, developing explanatory
concepts to link the themes where possible.
Results
Research from LICs is discounted early on
Our informants have extensive experience translating, or
attempting to translate, innovations from low-income
countries into the US, including conditional cash trans-
fer programs, community services, hospital accreditation
schemes, and educational policies such as teaching HIV
education in schools. Others have many years experience
at the executive levels of hospital and broader healthcare
systems or teach international health policy. Speaking to
their experience working with evidence from low-income
countries regarding innovations that they believed would
work well in the US, we asked whether they experienced
any particular reactions or sentiments during the persua-
sion process with colleagues or other actors in the US.
Informants consistently recognized that the source of the
innovation or the evidence seems to matter, and that, in
particular, evidence from low-income countries is often
discounted early on:
‘I’m certain that if I say, Narayana Heart Hospital [in
India] has lower infection rates than in the US, they’ll
be very skeptical, but if I were to say that the Hernia
Hospital in Montreal has better outcomes and lower
costs than any operations here, they would probably be
more receptive to that.’ (1st Oct 14 Professor of Law)
‘We had a conversation with a funder about a project
saying this model has been implemented in 12
different countries, all of them low income, we think
it has a lot of relevance for the US and we’d like to
bring it to the US. And they were really nervous,
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really nervous, really nervous. And then we said, oh
by the way, its actually also been adapted to the UK.
And all of a sudden they were like, oh, the UK, great.
It would probably work here then.’ (1st Oct 14
Manager, Innovation Think Tank)
The differentiated reaction noted above suggests that
attitudes towards evidence may change based merely on
knowledge of where such evidence is from. Many infor-
mants expressed a deep dissatisfaction with this, a sense
of injustice or unfairness, frustrating efforts to commu-
nicate evidence and experience from low-income coun-
tries, which in some cases could hold potential benefits
for US populations. These attitudes are important be-
cause without receptivity, persuasion of the potential
benefits of a new innovation or model becomes much
more difficult – breaking down barriers of prior expect-
ation and becoming a process of convincing rather
than learning. Informants recognized that it is not a
level xplaying field, and that in their experience actors
tend to downplay the effectiveness or benefits of an
innovation from a low-income country often drawing
on any number of reasons to refute or undermine the
validity and value of models that were from surprising
sources:
‘It was a very expected reaction….“of course they can
do it there. Everything’s cheap”’ (1st Oct 14 Director,
Innovation Think Tank)
The role and complexity of perceived context similarity
Examining more closely the reasons why these reactions
occur, informants noticed that it is not just because the
innovator context was foreign, but that it was different.
More specifically, that it was perceived to be different.
Informants noted that on the basis of perceived context
dissimilarity, the likelihood that actors would be more
receptive would decrease:
‘If the innovation is coming from a country that is
dissimilar to the system in which it is being donated,
or being suggested, to then that’s going to raise a certain
set of biases in the receiver that shuts them off – the
receptiveness to that.’ (10th Oct 14 Vice President,
Innovation Think Tank)
‘I think there’s a very kind of understandable, at least
initial, reaction that you want to look to places that are
maybe similar to you in economy or population, because
that may be where things are most transferable.’ (1st Oct
14 Director, Innovation Think Tank)
‘Canadians look more similar [to the US], many more
Americans have been, the visuals in the media are
more relatable, and so there’s a likeness that makes
people more willing to see that it could be applicable.’
(1st Oct 14 Senior Manager, Innovation Think Tank)
At first sight, this could pose little in the way of com-
plexity. By and large, we can conceive of countries as
having, broadly, some similar characteristics and intui-
tively the basis to looking towards countries that are
similar to one’s own seems sound. However, with prob-
ing, there also seemed to be very little consensus about
how contexts are perceived, and the criteria used to de-
scribe them. We asked the informants what were the
features of context that people bear in mind when they
make decisions about similarity and we could find very
little commonality in response. For some, the language
and cultural cues seemed important, for others the
socio-economic level, or the training of the health pro-
fessionals was important:
‘I think it probably depends on what domain one is
thinking of. We probably would presume, rightly or
wrongly, that other countries that speak English are
more like us than countries that don’t. I think we
would think other rich countries are more like us
than countries that are poor.’
(2nd Oct 14, Chief Executive, Health System)
I’m probably assuming income levels, education
levels, societal rules, laws and regulations, the role of
the Church…things of that nature. I think these are
natural things that one measures for growth and
development in a society….educational system, law
enforcement, what kind of opportunities do people
have, are they equal opportunities, how does business
function with government, is the system democratic
or dictatorial?’ (14th Oct 14 Board member,
Innovation Think Tank)
‘The other characteristics that people think of to
judge if their context is comparable to anothers….that
is an interesting question….there’s something around
sort of the training and licensing of providers….’ (1st
Oct 14, Manager, Innovation Think Tank)
‘It depends what hat I am wearing. Ask me as a health
policy person…well, you’ve got Canada with a very
different financing system but practice patterns that
don’t look all that different. Australia, mixed public/
private system, lots of private insurance. Brazil,
because of its reliance on private insurance for its
middle and upper classes. Canada, because of its
language and proximity. Its an interesting question
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because I have a little bit of knowledge and the
differences are quite real…really quite severe, at every
level. (15th Oct 14, Professor, Public Health)
Informants recognized that context similarity is based
not on data but on perceived characteristics and that de-
termination of which contexts could be construed as
similar to the US depended highly on the criteria that
one was considering. Nonetheless, each informant had
little difficulty stating, with some confidence, which
countries were, in their opinion, similar to the US or
completely dissimilar to the US:
‘Oh, I would guess China, Russia, to some extent
India, Congo, Nigeria, Venezuela, Argentina, probably,
Columbia, Jamaica…there are a number of countries
[that are too different to the US to learn from]’
(14th Oct 14, Board member, Innovation Think Tank)
‘I guess I’d say Canada, UK, maybe Japan [are the
most similar to the US]. Japan because we shaped so
much of its society after World War II. We really
rebuilt the society, the political system…and the way
of doing business.’ (14th Oct 14, Board member,
Innovation Think Tank)
‘People in the United States would look to Canada and
the UK as the two….you know, they’re English-speaking;
I mean we share a common history and, you know, I
think that differences between Canada, the US and the
UK are much smaller than they are with, really, any
other country…..(14th Nov 14, Vice President, Research
foundation)
although including the caveat, no less important, that
each person would likely have a different view:
‘Does it matter which country it [an innovation] came
from for transportability? I think probably the answer
is yes. I think some places are more likely to take up
the innovation because it comes from the US. Some
places may be more likely because it comes from
Europe or from China.’ (28th Oct 14, Professor,
Applied Psychology)
Conflating levels of analysis
Another issue is that there is a conflation of levels of
analysis. External validity or generalizability of an inter-
vention is a poorly defined construct as it is, and de-
pends on whether the causal mechanisms that explain
the interaction between an intervention and an outcome
in one context are present in another. Interventions
happen locally, requiring change agents, leaders and
managers, in local services. This nuance is lost, however,
when assumptions concerning the causal mechanisms at
a local level are conflated into national level characteris-
tics. Our informants describe a process where actors
seem to be drawing on country-level general characteris-
tics to explain causal mechanisms at the local level and
then to draw conclusions as to whether these causal
mechanisms exist in their own context. The success of
an intervention locally is unlikely to be, singularly, be-
cause of the GDP per capita of the country, and yet the
GDP per capita of the country, or other general mental
image, is used to ‘make the leap of faith’ about whether
this intervention would work in one’s own context:
‘If you imagine [the] infrastructure, like roads, and
schools, and governance systems look like yours, then
you can make the leap of faith that the medical
systems are similar enough…you could picture a
school in Canada being like a school in the US….you
sort of believe that its got the same active ingredients
that make it feel more similar to the US.’ (1st Oct 14,
Senior Manager, Innovation Think Tank)
‘I think part of it is preconceptions about how
generalizable things are. There are parts of North
Carolina that if you looked at a population, the
demographics would look almost entirely the same, or
with lower income groups, than parts of Kenya, parts
of India. When you generalize [though]…of course the
thing to say is that the [innovation] from Canada is
going to be more like what we would use and we would
need.’ (1st Oct 14, Director, Innovation Think Tank)
This is a mental shortcut that is probably pervasive,
and likely to be more pronounced for countries towards
which we either hold strong prior attitudes or know very
little about. Low-income countries, on the whole, fit this
category well because, within the US at least, it is likely
that actors will be less familiar with such contexts and
rely therefore on media representations that are, if any-
thing, presenting skewed and outdated images:
‘I don’t think that many individuals in this country are
well travelled enough to believe that those parts of the
world have health systems that could be operating
with a degree of functional excellence that could
make them relevant….If you have never been to India,
you will have an outdated view of it, from National
Geographic.’ (1st Oct 14, Senior Manager, Innovation
Think Tank)
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Succinctly summarized by the following narrative, the
informant’s observation that ‘they hear “Africa” and they
think there can’t be any good services’ is a worrying
exposé of the stereotypes occurring on a frequent basis.
Needless to say that not only is Africa not homogeneous,
but it also comprises hot spots of innovation that out-
perform high-income countries:
‘…they hear “Africa” and they think that there can’t be
any good services….and these are people in
Georgetown [very affluent neighborhood in
Washington DC] who travelled. It wasn’t like it was
people who had never left, not like in the hinterland.’
(24th Oct 14, Professor, Education Policy)
The significant generalization and over-simplification
that in turn influences one’s perceptions of what is or is
not possible lead people to hold, often firm, beliefs regard-
ing the fundamental capacity of the country to deliver
anything other than that which they expect from them:
‘I think that the starting position is we have nothing
to learn from these people….the fact that in India, in
selected circumstances, can deliver first world results
in highly complicated case, at a fraction of the cost is
simply dismissed as got to be sub-quality care…..when
you are sure of something, you don’t have to explain
it’ (15th Oct 14, Professor, Public Health)
Discussion
Our research highlights a particular problem in the Re-
verse Innovation process – that prior expectations, in-
voked by the LIC cue, are interfering with a transparent
and objective learning process. The informants, experi-
enced in transferring or attempting to transfer evidence
from low-income countries into the US context, describe
a prevalent application of stereotypes towards other
contexts, but particularly low-income countries. Actors
conflate local context with national context, and draw on
flimsy country-level conceptualizations to predict whether
what works in one context would or would not work in
their own. This process may occur with any context per-
ceived to be different to one’s own, but is more apparent
with low-income countries because these are less familiar,
and media representations are perhaps more stereotyped
than other contexts. The criteria with which people judge
one context to be or not be similar to one’s own seem
varied and diverse, but do not stop people from making
those judgments with some confidence. We expected
informants to cite technical differences between LICs and
HICs, for example disease profiles and case mix, but
instead general national stereotypes were more frequently
noted. Advancing on the ‘not-invented-here’ culture, we de-
scribe a ‘not-invented-in-a-context-perceived-to-be-similar-
to-here’ culture. From an evidence-based medicine perspec-
tive, this is less than desirable. Generalizability requires a
detailed knowledge of context so that the causal mecha-
nisms that explain the relationship between intervention
and outcome may be identified in one’s own context. Con-
text includes the structures and processes, the actors and
the institutions, that are involved in a change process and
that partially explain the relationship between an
intervention and an outcome. An intervention on its
own is necessary but not sufficient for an outcome.
The delivery model, how it was implemented, the specific
barriers and challenges, are part of the process too. Con-
sidering that no two contexts are the same, it does not fol-
low that an intervention successful (or unsuccessful) in
one location will automatically be successful in another. It
is necessary to ‘know deeply’ the innovator context so that
any inferences regarding transferability of an innovation
to one’s own context can be properly assessed. These local
explanatory variables are complex and certainly cannot be
inferred from national-level generalizations alone, how-
ever our informants’ experiences suggest that this is a
common occurrence. We interviewed informants from
education, social policy and international law, and found
that this experience is not unique to healthcare. McGill et
al. found that practitioners working in the design and
management of the built environment at local government
levels in the UK are more receptive to interventions that
have been ‘delivered in a similar country’ – although do not
discuss how these actors determine what does or does not
constitute similar [30]. Our research suggests that ‘similar-
ity’ is a flimsy, very personal construct based on conflated
micro and macro contextual characteristics and that this
leads to stereotyped generalizations that can interfere with
the Reverse Innovation process.
Although individuals may have explicit biases, implicit
biases are not tangible or tied to rational thought. Country
level stereotypes contribute to rash generalizations, and
these often-negative associations can appear outside of an
individual’s conscious awareness [5]. In an attempt to
translate the Brazilian Community Health Worker model
in to the health system in Wales, Johnson et al. describe
confronting issues of ‘pride’ and ‘prejudice’ during the
persuasion stage with local stakeholders [31]. Harris et al.
(forthcoming) have found that public health academics
rate research differently as a result of the source, in some
instances [32]. There has been an increased interest in the
psychology field in measuring aspects of thinking that
may not be overtly accessible to individual consciousness
[33] and there is now an extensive literature on what is re-
ferred to as the “introspectively unidentified” [34]. Judging
probability based on the essential features of a parent
population is a heuristic, a mental short cut, which in all
likelihood will be inaccurate and lead to false faith in some
cases, and missed opportunities in other cases [35].
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It is striking that although country of origin cues are
considered highly important in the marketing industry,
in healthcare research relatively little attention has been
given to how individual actors perceive the quality and
value of research or evidence from certain contexts. In
healthcare research, much more emphasis is placed on
the internal validity of the research, its conduct, risk of
bias, and fidelity to research methodology, the structural
and institutional ingredients to manage change and the
characteristics of the innovation itself. The marketing in-
dustry has developed techniques of counter-stereotyping
and branding to address potential biases towards certain
sources [5]. Perhaps these techniques could be adopted
in the health industry as well. Greenhalgh et al. note that
context and confounders lie at the very heart of diffusion
of complex innovations and are not extraneous to the ob-
ject of study; they are an integral part of it [2]. Rogers
touches on the idea of homophily as an impediment in
the adopter context, a sociological concept that individuals
have a tendency to associate with others of their same
kind [36]. Homophily is heightened within healthcare or-
ganizations [37] and narrows an individual’s social world,
leading to “herd” behavior [38, 39]. As a result of homo-
phily, individuals within the healthcare sector who are
most in need of innovation may actually be the least prone
to adopt it [40]. Nonetheless, curiously absent is examin-
ation of the impact of actor perceptions of the innovator
context. Considering that within countries, regions and
cities have different economic, social and cultural land-
scapes, country-level generalizations hold even less merit.
This study is not without its limitations. Our infor-
mants are all from the US context only and we have not
captured the views or experiences of front-line clinicians
or service users as this was beyond the scope of the
study and our resources. Although we have described
some valuable insights that might stimulate academic
debate we cannot generalize our findings to other con-
texts. Further research should be conducted in other
high-income contexts, broadening also the pool of re-
spondents to front-line clinicians and patients. Finally,
our interviews were a mix of telephone and face-to-face
interviews and it is possible that the different modes
might alter the responses. There are, however, lessons to
be learned by developed country health systems from
experiences in developing countries, and opportunities
for Reverse Innovation, where necessity and ingenuity
have overcome resource constraints to achieve positive
outcomes. We must allow ourselves to ‘know’ these con-
texts better before assuming they are too different for
any learning to hold merit [41].
Conclusion
Acknowledging the limitations of the research study, our
findings suggest that those interested in Reverse Innovation
should reflect carefully on the value of disclosing the source
of the innovation that is being proposed, if doing so is likely
to invoke negative stereotyping. There may be merit in
adopting some techniques from the cognitive psychology
and marketing literatures to understand better the rela-
tive importance of source in healthcare research and
innovation diffusion and efforts to develop counter-
stereotyping techniques may be useful in a diffusion of
innovation process.
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